STATUS QWO : CELLULITE HAS MET ITS MATCH WITH A NEW INJECTIBLE
Photo Credit: pexels.com
Cellulilte is one of those topics that most of us in the aesthetics space tend to be leery of. We’ve heard it all before; reduces dimples, pulverizes lumps and bumps, smooths skin, yada, yada, yada. These miracle cures often come with some discomfort, more downtime than expected, a longterm commitment to maintain the improvement, and a hefty price tag. Nonetheless, ‘cellulite’ continues to be a beauty buzzword that gets our attention because 80-90 percent of women, depending on who you ask, have it somewhere.
Enter QWO
The long awaited first-ever cellulite injectable, called QWO from Endo Pharmaceuticals (collagenase clostridium histolyticum-aaes) now has FDA approval, and the data is
BODY IS THE NEW FACE
Photo Credit: Depositphotos
Having a great body after having kids, used to be all about hard work and no carbs, but those days are so over. Thanks to an explosion in new fat reducing technology, slimmer hips, flatter tummies and shapelier curves are within every woman’s grasp.
And we are not talking about surgery either. The new generation of body contouring technologies are minimally invasive, and they are catching on. There were 180,000 non-surgical fat reduction treatments were performed in 2017, up almost 220% since 2012, according the latest statistics from the American Society for Aesthetic Plastic Surgery (ASAPS).
None of these are substitutes for eating a clean, healthy diet and getting regular exercise,
